首页> 外国专利> BLOOD-VESSEL THERAPEUTIC PATCH COMPOSED OF ENDOTHELIAL CELLS DERIVED FROM IPSCS PRE-TREATED WITH LEPTIN

BLOOD-VESSEL THERAPEUTIC PATCH COMPOSED OF ENDOTHELIAL CELLS DERIVED FROM IPSCS PRE-TREATED WITH LEPTIN

机译:瘦素预处理的IPSCS来源的内皮细胞组成的血管治疗斑块

摘要

Described herein are compositions and techniques related to generation of endothelial cells from pluripotent stem cells. Via leptin addition and activation of the canonical JAK/STAT pathway, vascular density improves in leptin-treated EBs compared to untreated controls in murine and human cells. Endothelial cell and angiogenesis marker expression analyzed via qRTPCR demonstrated elevated CD31 and phosphoSTAT3 (pSTAT3) expression. Such results allow for generation of therapeutic microvessels derived from pluripotent stem cells with enhanced capacity for angiogenesis and vasculogenesis, in addition to in vivo capillary network formation, thereby finding regenerative medicine applications for diseases such as diabetes and conditions such as burn victims.
机译:本文描述了与从多能干细胞产生内皮细胞有关的组合物和技术。通过瘦素的添加和经典JAK / STAT途径的激活,与未处理的鼠和人细胞对照相比,瘦素处理的EBs的血管密度得以改善。通过qRTPCR分析的内皮细胞和血管生成标记物表达证明CD31和phosphoSTAT3(pSTAT3)表达升高。这样的结果允许产生多能干细胞衍生的治疗性微血管,除了体内毛细血管网络形成,其还具有增强的血管生成和血管生成能力,从而发现了用于疾病如糖尿病和诸如烧伤患者的疾病的再生医学应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号